Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Merger
Merger
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merger
Emmaus Life Sciences Completes Merger
Biospace News
-
July 17, 2019
Merger
Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company
Merger
Gyroscope Therapeutics merges with Orbit Biomedical creating a leading retinal gene therapy company
Merger
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
Merger
X4 Pharmaceuticals Completes Merger with Arsanis
Merger
Oncternal and GTx to Merge, Form New Company Based in San...
Biospace News
-
March 7, 2019
0
- Advertisement -
MOST POPULAR
Direct-Acting Antivirals for Treating Hepatitis C Virus Affect Incidence of New-Onset...
March 8, 2019
Gossamer Bio, After a Game of Government Shutdown Roulette, Wins Big...
February 8, 2019
Amprologix secures funding to develop new antibiotic with Ingenza
February 8, 2019
Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization...
May 1, 2019
Load more
HOT NEWS
Commercial
Galapagos reports on historic first quarter 2019
Others
Scottish Medicines Consortium latanoprost + timolol (Fixapost)
Orphan-paediatric
Research Roundup: New Test for Autism and More
Commercial
Insmed To Showcase New ARIKAYCE (amikacin liposome inhalation suspension) And Pipeline...
